Case Report: Chemotherapy-free treatment with camrelizumab and anlotinib for elderly patients with KRAS and TP53 mutated advanced lung cancer

Background: Lung cancer is a major public health issue and an enormous burden on society in China. Most lung cancers occur in elderly patients with non-small cell lung cancer (NSCLC), and many factors limit their treatment options. Chemotherapy-free therapy can avoid psychological fear, treatment pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Wenbo, Xi, Dayong, Bai, Yuping, Liu, Le, Ma, Yanling, Yin, Zhenyu, Chen, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878280/
https://www.ncbi.nlm.nih.gov/pubmed/36713848
http://dx.doi.org/10.3389/fphar.2023.1026135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878280/
https://www.ncbi.nlm.nih.gov/pubmed/36713848
http://dx.doi.org/10.3389/fphar.2023.1026135

Ejemplares similares